Growth Metrics

Angiodynamics (ANGO) Total Non-Current Liabilities (2016 - 2026)

Angiodynamics' Total Non-Current Liabilities history spans 15 years, with the latest figure at $70.6 million for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities fell 14.06% year-over-year to $70.6 million; the TTM value through Feb 2026 reached $70.6 million, down 14.06%, while the annual FY2025 figure was $80.3 million, 16.39% down from the prior year.
  • Total Non-Current Liabilities reached $70.6 million in Q1 2026 per ANGO's latest filing, down from $76.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $149.8 million in Q2 2023 to a low of $63.2 million in Q3 2023.
  • Average Total Non-Current Liabilities over 5 years is $99.6 million, with a median of $92.9 million recorded in 2024.
  • The largest YoY upside for Total Non-Current Liabilities was 46.89% in 2023 against a maximum downside of 53.33% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $146.7 million in 2022, then plummeted by 34.71% to $95.8 million in 2023, then decreased by 2.99% to $92.9 million in 2024, then fell by 17.9% to $76.3 million in 2025, then decreased by 7.44% to $70.6 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Total Non-Current Liabilities are $70.6 million (Q1 2026), $76.3 million (Q4 2025), and $72.6 million (Q3 2025).